Debra has a 30+ year career as an accomplished strategic healthcare executive and entrepreneur with diverse and progressive product development and commercialization experience in global pharmaceutical and biomedical companies, including Centocor, GSK, Endo Pharmaceuticals and IMS Health.

Dr. David Cormode, PhD is Assistant Professor of Radiology at the University of Pennsylvania's Perleman School of Medicine. He has over 10 years of experience in the synthesis and development of nanoparticles. He is a co-founder of PolyAurum.

Dr. Andrew Tsourkas, PhD is Professor of Bioengineering at the University of Pennsylvania. He has over 15 years of experience in the development of nanoparticle medicines and is co-founder of 4 start-up biotechnology companies including PolyAurum.

Dr. Jay Dorsey, MD, PhD is Assistant Professor of Radiation Oncology at the University of Pennsylvania's Perleman School of Medicine. He is an expert in the development of novel radiotherapeutics and co-founder of 2 oncology-focused start-up companies including PolyAurum.

Dr. Rabe'e Cheheltani, PhD served as the teams entrepreneurial lead. She is a Postdoctoral Fellow in Radiology at the University of Pennsylvania's Perleman School of Medicine. She has 2 years of experience in developing and characterizing gold/biodegradable polyphosphazene nanoparticle formulations. She is a co-founder of PolyAurum.

Dr. Thais Sielecki, PhD is Chief Scientific Officer. She has more than 20 years of experience in drug development for large pharmaceutical companies such as Bristol Myers Squib and DuPont Merck and mid-sized companies such as Cytokine Pharmasciences. She has expertise in early development taking pharmaceutical assets from preclinical development through Phase II clinical studies.

Dr. Neha Saxena, PhD is Director of Product Development. She has responsibility for optimization and characterization of PolyAurum’s biodegradable gold nanoparticles. Dr Saxena has a broad background in biomaterials, including biodegradable hydrogel-based scaffolds for articular cartilage tissue engineering, nanoparticle-based tumor targeting and ablation, optimization of collagen mineralization process for bone and dental repair applications.